ArticleScientific reports2026
A functional variant in the porcine APOA2 promoter alters hepatic gene expression via RORα.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Apolipoprotein A2 is the second most abundant protein in high-density lipoproteins and plays an important role in lipid and glucose metabolism. APOA2 has been identified as a candidate gene influencing fat-related traits in pigs, and genetic variation has been associated with its hepatic expression. The aim of this study was to identify regulatory polymorphisms in the APOA2 promoter and assess their impact on gene expression. A total of 441 pigs from three backcross populations were analyzed. Four polymorphisms were identified in the APOA2 promoter, and a genome-wide association study identified rs339777757 as the most significant variant associated with APOA2 expression in liver. This variant is located at a predicted binding site of RORα, a nuclear receptor regulating apolipoprotein expression. RORα cotransfection with APOA2 promoter-driven luciferase constructs in HepG2 cells showed higher promoter activity of the rs339777757 C allele compared to the T allele. Our findings demonstrate that rs339777757 is a functional regulatory variant modulating APOA2 expression in the liver and support a functional role for RORα in this transcriptional regulatory mechanism. Since APOA2 plays a key role in lipid metabolism, this variant is likely to contribute to phenotypic variability in fat composition and meat quality traits, representing a potential target for improving pork quality. Additionally, these findings support the relevance of pigs as a model for studying metabolic regulation with potential implications for human health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.